Viewing nowMetin M Tablet 10 mg (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202003049 · Approved 2020.04.27
Treatment of moderate to severe Alzheimer's disease
This medication is used for patients with moderate to severe Alzheimer's disease. It helps improve memory and cognitive function, thereby assisting patients in conducting their daily lives more smoothly. It is effective in slowing the progression of symptoms or managing those symptoms. As a result, it contributes to improving the quality of life for both patients and their families. For these reasons, it is used to treat moderate to severe Alzheimer's disease.
Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. First week (Day 1~7) Administer 5mg daily for 7 days. Second week (Day 8~14) Administer 10mg daily for 7 days. Third week (Day 15~21) Administer 15mg daily for 7 days. From the fourth week onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dosage adjustment is necessary for patients with mild renal impairment (creatinine clearance: 50-80 mL/min). For patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. For patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is necessary for patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This drug should not be used in patients with hypersensitivity to its ingredients or severe liver or kidney dysfunction. Caution is required for patients with epilepsy or those who have experienced seizures in the past, as the risk of side effects may increase when taking certain NMDA antagonist drugs together. Patients with elevated urinary pH should also be carefully monitored, and there is insufficient clinical data available for patients with heart disease or uncontrolled hypertension, so caution is advised. When taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and additionally, central nervous system symptoms such as confusion, hallucinations, and seizures may appear. Moreover, this drug can interact with several other medications, so it is important to consult a doctor or pharmacist when taking it with NMDA antagonists, antipsychotics, antihypertensives, anticoagulants, etc. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication, and nursing mothers are advised to discontinue breastfeeding. It is preferable not to use this drug in children or adolescents under 18 years of age, as safety and efficacy have not been established. In the case of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, and immediate medical attention is required. This medication could affect a patient's response time and concentration, so caution is needed when driving or operating machinery. Finally, this medication should be kept out of the reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering and should preferably be kept at room temperature between 1°C and 30°C. By storing it this way, the medication's efficacy can be maintained, and degradation can be prevented.
White oblong film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.